Collateral for a security interest recorded Jul 15, 2019 (U.S. Bank National Association).
Term ended Apr 26, 2021 · High confidence
20-year base term ends May 4, 2037
Held by Aquestive Therapeutics, Inc.
Filed Oct 23, 2017 as application 15/791,249 · Granted Sep 30, 2025
Base term, 20 years from filing · capped by a resolved terminal disclaimer
Today
Term ended Apr 26, 2021
2017
2037
Clock starts
May 4, 2017
May 4, 2017
Term ended
Apr 26, 2021
Apr 26, 2021
Granted
Sep 30, 2025
Sep 30, 2025
base term
after the term ends
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 11,191,737, US 12,023,309, US 12,433,850.
None due
Maintenance fees
This term ends before the first maintenance fee's grace period does, 4 years from grant, so no fee can end it early.
9
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 4, 2017, when application 15/587,364, the earliest non-provisional in its chain, was filed (this one was filed Oct 23, 2017) | May 4, 2037 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,191,737, US 12,023,309, US 12,433,850) | capped to Apr 26, 2021 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | No maintenance fee can end the term early | term ended | High confidence |
| Computed term end | The steps above, in order | Apr 26, 2021 | High confidence |
This family
| US 11,191,737 | In force May 2037 | May 2037 |
| Application 15/717,859 | Abandoned not computed | not computed |
| US 12,427,121 | this patent Apr 2021 | Apr 2021 |
| US 12,433,850 | Term ended Apr 2021 | Apr 2021 |
| Application PCT/US2018/053042 | PCT application no patent term | no patent term |
| Application 17/514,805 | Abandoned not computed | not computed |
| Application 17/549,219 | Pending not computed | not computed |
| US 12,023,309 | Term ended Apr 2021 | Apr 2021 |
8 of 9 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 29, 2018 Reel 45196, frame 389 | MonoSol RX, LLC | Aquestive Therapeutics, Inc. | Change of Name |
| Jan 30, 2018 Reel 45279, frame 802 | Aquestive Therapeutics, Inc. | Perceptive Credit Holdings, LP | Amendment to Patent Security Agreement Recorded at Reel/Frame 039707/0194 |
| Apr 2, 2018 Reel 45415, frame 663 | Schobel, Alexander Mark; Varjan, Stephanie Marie; Wargacki, Stephen Paul | Aquestive Therapeutics, Inc. | Assignment of Assignor's Interest |
| Jul 15, 2019 Reel 49758, frame 82 | Aquestive Therapeutics, Inc. | U.S. Bank National Association | Security Interest |
| Jul 15, 2019 Reel 49757, frame 733 | Perceptive Credit Holdings, LP | Aquestive Therapeutics, Inc.; MonoSol RX, Inc.; MSRX US, LLC | Release of Security Interest |
| Jul 15, 2019 reel/frame not recorded | Perceptive Credit Holdings, LP | Aquestive Therapeutics, Inc. | Release of Security Interest |
| Jul 15, 2019 reel/frame not recorded | Perceptive Credit Holdings, LP | MonoSol RX, Inc. | Release of Security Interest |
| Jul 15, 2019 reel/frame not recorded | Perceptive Credit Holdings, LP | MSRX US, LLC | Release of Security Interest |
| Nov 1, 2023 Reel 65426, frame 642 | U.S. Bank Trust Company National Association (as Successor in Interest to U.S Bank National Association) | Aquestive Therapeutics, Inc. | Release of Security Interest |
| Nov 2, 2023 Reel 65446, frame 494 | Aquestive Therapeutics, Inc. | U.S. Bank Trust Company, National Association | Security Interest |
| May 12, 2026 Reel 75561, frame 782 | Aquestive Therapeutics, Inc. | Oaktree Fund Administration, LLC, as Administrative Agent | Security Interest |
| May 13, 2026 Reel 75646, frame 258 | U.S. Bank Trust Company, National Association | Aquestive Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 11,191,737, US 12,023,309, US 12,433,850.
Citations
5
later US patents cite this one
Fewer than half of the utility patents granted in 2025 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.